Aim: New parameters are emerging to predict prognosis in patients with ST-segment elevation myocardial infarction (STEMI). In this study we aimed to determine and compare the prognostic values of some metabolic indices in terms of predicting long-term mortality in patients with STEMI. Method: A total of 1900 nondiabetic patients who presented with STEMI and underwent percutaneous coronary intervention were included in the study. Multivariable Cox proportional regression analysis was used to determine and compare the predictive performance of triglyceride–glucose (TyG) index, triglyceride–high-density lipoprotein ratio (Ty/HDL) and admission glucose. Results: In multivariable Cox regression analysis, the model based on TyG index had better predictive performance than the Ty/HDL and admission blood glucose. Conclusion: The TyG index is more informative than Ty/HDL and admission glucose level to predict long-term all-cause mortality.

Keywords:

References

1. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053), 1459–1544 (2016).
MedlineGoogle Scholar
2. Roth GA, Abate D, Abate KH. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159), 1736–1788 (2018).
MedlineGoogle Scholar
3. Akyea RK, Leonardi-Bee J, Asselbergs FW et al. Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models. BMJ Open 10, e034564 (2020).
MedlineGoogle Scholar
4. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 14(2), 88–98 (2018).
MedlineGoogle Scholar
5. Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat. Rev. Endocrinol. 10(5), 293 (2014).
Medline CASGoogle Scholar
6. De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti DP. Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links. Front. Endocrinol. 9, 2 (2018).
MedlineGoogle Scholar
7. Pacifico L, Bonci E, Andreoli G et al. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents. Nutr. Metab. Cardiovasc. Dis. 24(7), 737–743 (2014).
Medline CASGoogle Scholar
8. Lamarche B, Després JP, Moorjani S, Cantin B, Dagenais GR, Lupien P-J. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Quebec cardiovascular study. Atherosclerosis 119(2), 235–245 (1996).
Medline CASGoogle Scholar
9. Jin JL, Cao YX, Wu LG et al. Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease. J. Thorac. Dis. 10(11), 6137–6146 (2018).
MedlineGoogle Scholar
10. Wang L, Cong HL, Zhang JX et al. Triglyceride–glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 19(1), 80 (2020).
Medline CASGoogle Scholar
11. Zhang Y, Ding X, Hua B et al. High triglyceride–glucose index associated with adverse cardiovascular outcomes in patients with acute myocardial infarction. Nutrition 30(12), 2351–2362 (2020).
CASGoogle Scholar
12. Luo E, Wang D, Yan G et al. High triglyceride–glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc. Diabetol. 18, 150 (2019).
MedlineGoogle Scholar
13. Alavi-Moghaddam M, Parsa-Mahjoob M, Ghodssi-Ghassemabadi R, Bitazar B. Association of admission blood glucose level with major adverse cardiac events in acute coronary syndrome; a cohort study. Arch. Acad. Emerg. Med. 7(1), e26 (2019).
MedlineGoogle Scholar
14. Hao ZX, Liu Y, Wang DL et al. Impact of admission glucose on non-diabetic patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: a meta-analysis. Acta Cardiol. Sin. 32(2), 194–204 (2016).
MedlineGoogle Scholar
15. Thygesen K, Alpert JS, White HD et al. Universal definition of myocardial infarction. Eur. Heart J. 28(20), 2525–2538 (2007).
MedlineGoogle Scholar
16. Scanlon PJ, Faxon DP, Audet AM et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J. Am. Coll. Cardiol. 33(6), 1756–1824 (1999).
Medline CASGoogle Scholar
17. Cheitlin MD, Alpert JS, Armstrong WF et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation 95(6), 1686–1744 (1997).
Medline CASGoogle Scholar
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl. 1), S62–9 (2010).
MedlineGoogle Scholar
19. Björk M, Melin EO, Frisk T, Thunander M. Admission glucose level was associated with increased short-term mortality and length-of-stay irrespective of diagnosis, treating medical specialty or concomitant laboratory values. Eur. J. Intern. Med. 75, 71–78 (2020).
MedlineGoogle Scholar
20. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab. Syndr. Relat. Disord. 6(4), 299–304 (2008).
Medline CASGoogle Scholar
21. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 96(8), 2520–2525 (1997).
Medline CASGoogle Scholar
22. Ambinder EP. Electronic health records. J. Oncol. Pract. 1(2), 57–63 (2005).
MedlineGoogle Scholar
23. Hadaegh F, Khalili D, Ghasemi A et al. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr. Metab. Cardiovasc. Dis. 19(6), 401–408 (2008).
MedlineGoogle Scholar
24. Vega GL, Barlow CE, Grundy SM, Leonard D, De Fina LF. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. J. Investig. Med. 62(2), 345–349 (2014).
Medline CASGoogle Scholar
25. Wang C, Li F, Guo J, Li C, Xu D, Wang B. Insulin resistance, blood glucose and inflammatory cytokine levels are risk factors for cardiovascular events in diabetic patients complicated with coronary heart disease. Exp. Ther. Med. 15(2), 1515–1519 (2018).
Medline CASGoogle Scholar
26. Tanriverdi Z, Colluoglu T, Dursun H, Kaya D. The relationship between neutrophil-to-lymphocyte ratio and fragmented QRS in acute STEMI patients treated with primary PCI. J. Electrocardiol. 50(6), 876–883 (2017).
MedlineGoogle Scholar
27. Wang H, Liu Z, Shao J et al. Immune and inflammation in acute coronary syndrome: molecular mechanisms and therapeutic implications. J. Immunol. Res. 2020, 4904217 (2020).
MedlineGoogle Scholar
28. Ong SB, Hernández-Reséndiz S, Crespo-Avilan GE et al. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol. Ther. 186, 73–87 (2018).
Medline CASGoogle Scholar
29. Videbaek J, Christensen NJ, Sterndorff B. Serial determination of plasma catecholamines in myocardial infarction. Circulation 46, 846–855 (1972).
Medline CASGoogle Scholar
30. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit. Care Clin. 17, 107–124 (2001).
Medline CASGoogle Scholar
31. Whicher JT, Westacott CI. The acute phase response. In: Biochemistry of Inflammation. Immunology and Medicine Series (Vol. 18). Whicher JTEvans SW (Eds). Springer, Dordrecht, The Netherlands (1992).
Google Scholar
32. Kushner I, Gewurz H, Benson MD. C-reactive protein and acute-phase response. J. Lab. Clin. Med. 97, 739–749 (1981).
Medline CASGoogle Scholar
33. Behr SR, Patsch JR, Forte T, Bensadoun A. Plasma lipoprotein changes resulting from immunologically blocked lipolysis. J. Lipid Res. 22, 443–451 (1981).
Medline CASGoogle Scholar
34. Pitt B, Loscalzo J, Yčas J, Raichlen JS. Lipid levels after acute coronary syndromes. J. Am. Coll. Cardiol. 51(15), 1440–1445 (2008).
Medline CASGoogle Scholar
35. Rosenson RS. Myocardial injury the acute phase response and lipoprotein metabolism. J. Am. Coll. Cardiol. 22(3), 933–940 (1993).
Medline CASGoogle Scholar
36. Balci B. The modification of serum lipids after acute coronary syndrome and importance in clinical practice. Curr. Cardiol. Rev. 7(4), 272–276 (2011).
Medline CASGoogle Scholar
37. Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat. Rev. Endocrinol. 10(5), 293–302 (2014).
Medline CASGoogle Scholar
38. Reaven GM, Lerner RL, Stern MP, Farquhar JW. Role of insulin in endogenous hypertriglyceridemia. J. Clin. Invest. 46(11), 1756–1767 (1967).
Medline CASGoogle Scholar
39. Howard G, O’Leary DH, Zaccaro D et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 93(10), 1809–1817 (1996).
Medline CASGoogle Scholar
40. Laakso M, Sarlund H, Salonen R et al. Asymptomatic atherosclerosis and insulin resistance. Arterioscler. Thromb. 11(4), 1068–1076 (1991).
Medline CASGoogle Scholar
41. Bressler P, Bailey SR, Matsuda M, DeFronzo RA. Insulin resistance and coronary artery disease. Diabetologia 39(11), 1345–1350 (1996).
Medline CASGoogle Scholar
42. Sesti G. Pathophysiology of insulin resistance. Best. Pract. Res. Clin. Endocrinol. Metab. 20(4), 665–679 (2006).
Medline CASGoogle Scholar
43. Stegenga ME, van der Crabben SN, Levi M et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes 55(6), 1807–1812 (2006).
Medline CASGoogle Scholar
44. Figtree GA, Vernon ST, Hadziosmanovic N et al. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data. Lancet 397(10279), 1085–1094 (2021).
Medline CASGoogle Scholar

Vol. 16, No. 8

Metrics

Downloaded 80 times

History

Received 2 December 2021

Accepted 31 March 2022

Published online 27 April 2022

Published in print June 2022

Information

Keywords

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Ethical conduct of research

This study was approved by the Ethics Committee of Kosuyolu Research and Training Hospital.

PDF download